PAQR5 and hepatocellular carcinoma: First, the datasets used lacked detailed information on chemotherapy and targeted therapy, limiting the ability to assess patient prognosis comprehensively., Secondly, additional studies are needed to clarify the specific mechanisms by which PAQR5 regulates the NF-κB signaling pathway in HCC.